These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 27905217)

  • 41. Gene editing and its application for hematological diseases.
    Osborn MJ; Belanto JJ; Tolar J; Voytas DF
    Int J Hematol; 2016 Jul; 104(1):18-28. PubMed ID: 27233509
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CRISPR-Cas systems: Challenges and future prospects.
    Gohil N; Bhattacharjee G; Lam NL; Perli SD; Singh V
    Prog Mol Biol Transl Sci; 2021; 180():141-151. PubMed ID: 33934835
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CRISPR Mediated Genome Engineering and its Application in Industry.
    Kaboli S; Babazada H
    Curr Issues Mol Biol; 2018; 26():81-92. PubMed ID: 28879858
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Designed nucleases for targeted genome editing.
    Lee J; Chung JH; Kim HM; Kim DW; Kim H
    Plant Biotechnol J; 2016 Feb; 14(2):448-62. PubMed ID: 26369767
    [TBL] [Abstract][Full Text] [Related]  

  • 45. RNA-dependent DNA endonuclease Cas9 of the CRISPR system: Holy Grail of genome editing?
    Gasiunas G; Siksnys V
    Trends Microbiol; 2013 Nov; 21(11):562-7. PubMed ID: 24095303
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mouse genome engineering using designer nucleases.
    Hermann M; Cermak T; Voytas DF; Pelczar P
    J Vis Exp; 2014 Apr; (86):. PubMed ID: 24747757
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genome editing and the next generation of antiviral therapy.
    Stone D; Niyonzima N; Jerome KR
    Hum Genet; 2016 Sep; 135(9):1071-82. PubMed ID: 27272125
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Progress in and Prospects of Genome Editing Tools for Human Disease Model Development and Therapeutic Applications.
    Phan HTL; Kim K; Lee H; Seong JK
    Genes (Basel); 2023 Feb; 14(2):. PubMed ID: 36833410
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [CRISPR/Cas9 technology in disease research and therapy: a review].
    Shi M; Shen Z; Zhang N; Wang L; Yu C; Yang Z
    Sheng Wu Gong Cheng Xue Bao; 2021 Apr; 37(4):1205-1228. PubMed ID: 33973436
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Progress of new-generation genome editing mediated by engineered endonucleases].
    Xiao A; Zhang B
    Sheng Wu Gong Cheng Xue Bao; 2015 Jun; 31(6):917-28. PubMed ID: 26672367
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The zebrafish genome editing toolkit.
    Ata H; Clark KJ; Ekker SC
    Methods Cell Biol; 2016; 135():149-70. PubMed ID: 27443924
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recent advances in CRISPR/Cas9 mediated genome editing in Bacillus subtilis.
    Hong KQ; Liu DY; Chen T; Wang ZW
    World J Microbiol Biotechnol; 2018 Sep; 34(10):153. PubMed ID: 30269229
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genome Editing of Rat.
    Kaneko T
    Methods Mol Biol; 2023; 2637():223-231. PubMed ID: 36773150
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Engineered Viruses as Genome Editing Devices.
    Chen X; Gonçalves MA
    Mol Ther; 2016 Mar; 24(3):447-57. PubMed ID: 26336974
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The CRISPR/Cas9 system for plant genome editing and beyond.
    Bortesi L; Fischer R
    Biotechnol Adv; 2015; 33(1):41-52. PubMed ID: 25536441
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The research advances and applications of genome editing in hereditary eye diseases].
    Cai SW; Zhang Y; Hou MZ; Liu Y; Li XR
    Zhonghua Yan Ke Za Zhi; 2017 May; 53(5):386-391. PubMed ID: 28494568
    [TBL] [Abstract][Full Text] [Related]  

  • 57. From Gene Targeting to Genome Editing: Transgenic animals applications and beyond.
    Rocha-Martins M; Cavalheiro GR; Matos-Rodrigues GE; Martins RA
    An Acad Bras Cienc; 2015 Aug; 87(2 Suppl):1323-48. PubMed ID: 26397828
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development of CRISPR/Cas9 system for targeted DNA modifications and recent improvements in modification efficiency and specificity.
    Shin J; Oh JW
    BMB Rep; 2020 Jul; 53(7):341-348. PubMed ID: 32580834
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluating and Enhancing Target Specificity of Gene-Editing Nucleases and Deaminases.
    Kim D; Luk K; Wolfe SA; Kim JS
    Annu Rev Biochem; 2019 Jun; 88():191-220. PubMed ID: 30883196
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Making designer mutants in model organisms.
    Peng Y; Clark KJ; Campbell JM; Panetta MR; Guo Y; Ekker SC
    Development; 2014 Nov; 141(21):4042-54. PubMed ID: 25336735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.